ANALYTICAL DIAGNOSTIC SOLUTIONS INC
Mount Laurel, NJ · Medtech · Private
PreQuine Platform - a point-of-care diagnostic meter and test strips that simultaneously screen for G6PD enzyme levels and hemoglobin, paired with mobile app for patient tracking and clinician connect
- Grants
- $11M
- 16 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 2 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A user-friendly point-of-care device for G6PDH determination | $191,220 | |
| Federal grant | Department of Health and Human Services · Phase I · A user friendly point of care device for G PDH determination | $191,220 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: A user-friendly point-of-care device for simultaneous G6PDH and hemoglobin determination | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · A point-of-care device for phenylalanine determination | $224,700 | |
| Federal grant | Department of Health and Human Services · Phase I · A point-of-care device for the determination of the Bilirubin, the BiliNow | $224,700 | |
| Federal grant | Department of Health and Human Services · Phase II · A user-friendly point-of-care device for G6PDH determination | $873,090 | |
| Federal grant | Department of Health and Human Services · Phase II · A user-friendly point-of-care device for G6PDH determination | $1,447,330 | |
| Federal grant | Department of Health and Human Services · Phase II · A user-friendly point-of-care device for G6PDH determination | $574,240 | |
| Federal grant | Department of Health and Human Services · Phase II · A point-of-care device for phenylalanine determination | $944,873 | |
| Federal grant | Department of Health and Human Services · Phase II · A point-of-care device for phenylalanine determination | $1,002,084 | |
| Federal grant | Department of Health and Human Services · Phase II · PreQuine Platform. A novel point of care device for the diagnosis andmonitoring of Glucose-6-Phosphate Dehydrogenase (G6PD) | $2,893,164 | |
| Federal grant | Department of Health and Human Services · Phase I · ADA2 Diagnostic Platform: Point-of-care test for determination of patient enzyme levels for diagnosis of the rare disease Deaminase2 Deficiency (DADA2) | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · PKU Now-Connect: An intelligent digital ecosystem to improve health outcomes in Phenylketonuria | $291,361 | |
| Federal grant | Department of Health and Human Services · Phase I · A point of care-device for the determination of creatinine phosphokinase (CPK), the CPK Now | $295,923 | |
| Federal grant | Department of Health and Human Services · Phase I · A point-of-care device for the determination of homocysteine (Hcy), the Hcy Now | $305,352 | |
| Federal grant | Department of Health and Human Services · Phase II · A point of care-device for the determination of creatinine phosphokinase (CPK), theCPK Now | $906,002 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1176 | ARC Bio, LLC | — | — |
| 1177 | MARVEL MEDTECH, LLC | — | — |
| 1178 | EvoEndo, Inc. | — | $4.7M |
| 1179 | ANALYTICAL DIAGNOSTIC SOLUTIONS INC | — | — |
| 1180 | IMMUNO TECHNOLOGIES INC | — | — |
| 1181 | PERFUSIO CORP. | — | $11M |
| 1182 | INIA BIOSCIENCES, INC. | — | $200K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Universal Stand For Holding Capillary And Transfer Pipettesapplication
- Point-of-care Device For The Colorimetric Determination Of Hemoglobin And GLUCOSE-6-PHOSPHATE Dehydrogenase In Biological Samplesgranted
- Point-of-care Device for the Colorimetric Determination of L-Phenylalanine in Biological Samplesgranted
- Point-of-care Device For The Quantitative Determination Of Branched-chain Amino Acids In Biological Samplesapplication
- Point-of-care Device For The Quantitative Determination Of Branched-chain Amino Acids In Biological Samplesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.